France 2030 | "Emerging infectious diseases" strategy: three years of action to prepare for the future

Event 1 October 2024
The Innovation santé 2030 plan, the health component of the France 2030 investment plan, was announced in the thick of the Covid-19 epidemic, and naturally pinpointed the fight against emerging infectious diseases and NRBC (nuclear, radiological, biological and chemical) threats as one of France's major strategic priorities.To measure progress on the various measures planned and assess what remains to be done to be able to cope with a new epidemic, the Agence de l'innovation en santé and its various partners organized a days of meetings in Montpellier on 30 September 2024.

ÌÇÐÄVlog's Aurélie Binot contributed to a roundtable on preparation for and management of health crises © F. Gaudin, Agence de l'innovation en santé

Preparing for and fighting emerging infectious diseases is one of five priority topics identified in the Innovation santé (health innovation) 2030 plan, the health component of the France 2030 investment plan. It benefits from a specific strategy with a substantial budget, coordinated by the Agence de l'innovation en santé in conjunction with the Ministries of the Armed Forces, for Ecological Transition, of Health and Access to Healthcare, of Agriculture, of Higher Education and Research, and of Industry. The main aim is to boost systemic preparedness for the risks of major new health risks. This involves coordinating the structures responsible for those aspects and improving response capacity on a national level, as well as within Europe and worldwide. The Maladies infectieuses émergentes - menaces NRBC (Emerging infectious diseases - NRBC threats) strategy fits in with the One Health principle, recognizing the links between human, animal and ecosystem health in order to pinpoint the factors that influence the conditions for and frequency of emergence.

To mark the strategy's third anniversary, the Agence de l'innovation en santé, ANRS Maladies infectieuses émergentes (MIE) (a national health research agency), IRD, INRAE and ÌÇÐÄVlog organized a day of meetings at Montpellier's Corum Centre on 30 September, to take stock of progress on the different operations under way in terms of research, innovation, industrialization and training, meet France 2030 prize-winners and work together to assess what operations should be consolidated or launched. The aim is to put France on the podium of European countries as regards crisis response capacity, by means of a coordinated strategy centring on proactive planning.

A day to take stock of progress on winning projects in the field of emerging infectious diseases

The meetings brought together more than 250 participants, with sessions on research, innovation, industrialization, crisis management and training. Presentations from the various winners and posters on the winning projects provided concrete proof of the progress made.

The meetings also served to honour the latest winners: the four winning projects to set up platforms to demonstrate and validate counter-measures, and a third École Universitaire de Recherche (university research college), UN ITEID.

Issues that mean adapting certain actions set out in the strategy

The various sessions served to look at the operations to be consolidated or launched to put France on the podium of European countries as regards crisis response capacity, by means of a coordinated strategy centring on proactive planning:

  • Broadening the ecosystem to include new skills and firms in terms of emerging infectious diseases and NRBC threats
  • Imagining economical solutions in line with emerging infectious disease and NRBC threat markets
  • Optimizing coordination, to switch from a reactive to a proactive planning approach
  • Facilitating the integration of human and animal health within industry
  • Boosting France's influence on a European and global scale.

ÌÇÐÄVlog – along with IRD and INRAE – is involved in steering the PREZODE Priority Research Programme and Infrastructure (PEPR), which is part of the strategy's "research" component, and in particular in two of the : ZOOCAM, centred on Camargue, and ARCHE, targeting Crimean-Congo haemorrhagic fever.